Endeavor BioMedicines Secures $132.5M for Medical Breakthroughs

April 25, 2024, 3:32 pm
Endeavor Biomedicines
Endeavor Biomedicines
Location: United States, California, San Diego
Employees: 11-50
Founded date: 2018
Total raised: $295.5M
San Diego's Endeavor BioMedicines has clinched a hefty $132.5M in Series C financing, spearheaded by AyurMaya and a lineup of heavyweight investors. This injection of funds will propel the clinical development of ENV-101, targeting fibrotic lung diseases, and ENV-501, a cutting-edge HER3-targeted antibody-drug conjugate for solid tumors. Led by visionary John Hood, Endeavor BioMedicines is on a mission to revolutionize patient care with groundbreaking treatments.